Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

570 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
GLP-1 Receptor Agonist Effects on Lipid and Liver Profiles in Patients with Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis.
Rezaei S, Tabrizi R, Nowrouzi-Sohrabi P, Jalali M, Atkin SL, Al-Rasadi K, Jamialahmadi T, Sahebkar A. Rezaei S, et al. Among authors: jalali m. Can J Gastroenterol Hepatol. 2021 Nov 12;2021:8936865. doi: 10.1155/2021/8936865. eCollection 2021. Can J Gastroenterol Hepatol. 2021. PMID: 34805029 Free PMC article. Review.
The effects of curcumin supplementation on liver function, metabolic profile and body composition in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
Jalali M, Mahmoodi M, Mosallanezhad Z, Jalali R, Imanieh MH, Moosavian SP. Jalali M, et al. Among authors: jalali r. Complement Ther Med. 2020 Jan;48:102283. doi: 10.1016/j.ctim.2019.102283. Epub 2019 Dec 17. Complement Ther Med. 2020. PMID: 31987259
The effects of metformin administration on liver enzymes and body composition in non-diabetic patients with non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis: An up-to date systematic review and meta-analysis of randomized controlled trials.
Jalali M, Rahimlou M, Mahmoodi M, Moosavian SP, Symonds ME, Jalali R, Zare M, Imanieh MH, Stasi C. Jalali M, et al. Among authors: jalali r. Pharmacol Res. 2020 Sep;159:104799. doi: 10.1016/j.phrs.2020.104799. Epub 2020 Apr 8. Pharmacol Res. 2020. PMID: 32278041
The effect of voglibose on metabolic profiles in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of clinical trials.
Nowrouzi-Sohrabi P, Tabrizi R, Rezaei S, Jafari F, Hessami K, Abedi M, Jalali M, Keshavarzi P, Shahabi S, Kolahi AA, Carson-Chahhoud K, Sahebkar A, Safiri S. Nowrouzi-Sohrabi P, et al. Among authors: jalali m. Pharmacol Res. 2020 Sep;159:104988. doi: 10.1016/j.phrs.2020.104988. Epub 2020 Jun 3. Pharmacol Res. 2020. PMID: 32504833
Effect of soy consumption on liver enzymes, lipid profile, anthropometry indices, and oxidative stress in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of clinical trials.
Zarei A, Stasi C, Mahmoodi M, Masoumi SJ, Zare M, Jalali M. Zarei A, et al. Among authors: jalali m. Iran J Basic Med Sci. 2020 Oct;23(10):1245-1250. doi: 10.22038/ijbms.2020.46854.10797. Iran J Basic Med Sci. 2020. PMID: 33149855 Free PMC article. Review.
The effects of glucagon-like peptide-1 receptor agonists on glycemic control and anthropometric profiles among diabetic patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
Nowrouzi-Sohrabi P, Rezaei S, Jalali M, Ashourpour M, Ahmadipour A, Keshavarz P, Akbari H. Nowrouzi-Sohrabi P, et al. Among authors: jalali m. Eur J Pharmacol. 2021 Feb 15;893:173823. doi: 10.1016/j.ejphar.2020.173823. Epub 2020 Dec 19. Eur J Pharmacol. 2021. PMID: 33352183
570 results